Sam Chun Dang Pharm. Co. Ltd (000250) — Cash Flow Quality Index
Sam Chun Dang Pharm. Co. Ltd (000250) has a Cash Flow Quality Index of 0.96x as of March 2025. Operating cash flow of ₩1.23 Billion is below net income of ₩1.28 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Sam Chun Dang Pharm. Co. Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sam Chun Dang Pharm. Co. Ltd Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000250 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sam Chun Dang Pharm. Co. Ltd (2012–2022)
Year-by-year earnings quality comparison for Sam Chun Dang Pharm. Co. Ltd. For live market cap and the full company financial profile, see 000250 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 2.27x | ₩13.28 Billion | ₩5.84 Billion | ▲ +55.3% |
| 2019 | 1.46x | ₩30.60 Billion | ₩20.89 Billion | ▼ -20.7% |
| 2018 | 1.85x | ₩25.03 Billion | ₩13.55 Billion | ▼ -11.4% |
| 2017 | 2.08x | ₩26.09 Billion | ₩12.51 Billion | ▲ +83.2% |
| 2016 | 1.14x | ₩17.76 Billion | ₩15.61 Billion | ▲ +17.3% |
| 2015 | 0.97x | ₩17.34 Billion | ₩17.87 Billion | ▼ -41.2% |
| 2014 | 1.65x | ₩19.55 Billion | ₩11.85 Billion | ▼ -9.7% |
| 2013 | 1.83x | ₩15.94 Billion | ₩8.72 Billion | ▲ +52.9% |
| 2012 | 1.20x | ₩1.60 Billion | ₩1.34 Billion | — |